当前位置：药药网 / 数据中心 /靶点针对疾病信息(本栏目收费,不能显示细节,电话13136136841)
靶点针对疾病信息29(本栏目收费,不能显示细节,电话13136136841)
靶点针对疾病信息
INDICATI
Withdrawn from market Gout [ICD-11: FA25]
INDICATI
Discontinued in Phase 3 General pain disorder [ICD-11: 8E43]
INDICATI
Discontinued in Phase 3 Lupus erythematosus [ICD-11: 4A40]
INDICATI
Discontinued in Phase 3 Postoperative inflammation [ICD-11: 1A00-CA43]
INDICATI
Discontinued in Phase 2 Large intestine polyp [ICD-11: DB35]
INDICATI
Discontinued in Phase 2 Lung cancer [ICD-11: 2C25]
INDICATI
Discontinued in Phase 2 Type 2 diabetes mellitus [ICD-11: 5A11]